XML 65 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Feb. 14, 2024
Jun. 28, 2023
Nov. 08, 2021
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Dec. 31, 2022
Subsidiary, Sale of Stock [Line Items]              
Cash equivalents           $ 0 $ 0
Offering costs $ 229,328     $ 7,499,353    
Deferred underwriting fee payable           14,700,000 14,700,000
Number of shares issued       164,614,418      
Federal depository insurance coverage amount           250,000  
Impairment of due from related party           250,000
Unrecognized tax benefits           0 0
Unrecognized tax benefits accrued for interest and penalties           $ 0 $ 0
Number of shares excluded from computation of diluted earnings per ordinary share       65,575,576 13,301,863    
Warrant [Member]              
Subsidiary, Sale of Stock [Line Items]              
Number of warrants issued to purchase ordinary shares (in shares)     17,975,000        
Exercise price of warrants     $ 11.50        
Number of shares excluded from computation of diluted earnings per ordinary share           17,975,000 17,975,000
Common Class A [Member]              
Subsidiary, Sale of Stock [Line Items]              
Temporary equity, shares outstanding           1,502,180 34,500,000
IPO [Member]              
Subsidiary, Sale of Stock [Line Items]              
Offering costs     $ 21,266,594        
Underwriting fees     6,000,000        
Deferred underwriting fee payable     14,700,000        
Other offering costs     $ 566,594        
IPO [Member] | Fee Reduction Agreement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Deferred underwriting fee payable   $ 5,000,000          
Number of shares issued   500,000